Liver cancer drugs tecentriq and bevacizumab to receive Pharmac funding
The two drugs in combination will help New Zealanders diagnosed with Hepatocellular Carcinoma (HCC). Photo: 123RF One of the world's most globally recognised liver cancer treatments will receive public funding from today. Tecentriq (atezolizumab) in …